The 3 linked references in paper А. Эрлих Д. (2014) “ДВОЙНАЯ АНТИТРОМБОЦИТАРНАЯ ТЕРАПИЯ: НЕОБХОДИМОСТЬ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ И ВОЗМОЖНОСТИ ЕЕ ПОВЫШЕНИЯ” / spz:neicon:aterotromboz:y:2014:i:2:p:25-33

  1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 2011, doi:10.1093/eurheartj/ehr236.
  2. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal, 2012, doi:10.1093/eurheartj/ehS215.
  3. Varenhorst C, Jensevik K, Jernberg T et al. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with actue coronary syndrome. Eur Heart J, 2013, DOI:10.1093/eurheartj/eht438. Доступно: http://eurheartj.oxfordjournals.org.